Literature DB >> 21325347

Perforating vein fistula is superior to forearm fistula in elderly haemodialysis patients with diabetes and arterial hypertension.

Daniel Palmes1, Linus Kebschull, Roland M Schaefer, Friedrich Pelster, Klaus Konner.   

Abstract

BACKGROUND: Access-related problems are one of the major causes of morbidity in elderly patients with chronic kidney disease. The aim of this study was to assess potential risks and benefits in elderly patients comparing forearm arteriovenous fistula (AVF) and perforating vein AVF below the elbow for primary vascular access.
METHODS: A retrospective comparison of elderly patients (65.7 ± 9.3 years, 70.4% male patients, 36.2% late referral) undergoing primary vascular access surgery using forearm AVF (n = 50) and perforating vein AVF (n = 55) was performed over a 2-year period, including a multivariate analysis of potential risk factors and benefits of primary patency (PP = intervention-free access survival) and secondary patency (SP = access survival until abandonment).
RESULTS: Patency rates after 24 months were significantly higher in patients with perforating vein AVF (PP + SP: 78.2%) compared to forearm AVF (PP: 62%, SP: 56%, P = 0.04). Presence of diabetes mellitus in patients with forearm AVF was associated with a decreased PP [odds ratio (OR): 3.6, 95% confidence interval (CI): 0.9-13.8] and SP (OR: 4.8, 95% CI: 1.3-17.9), and arterial hypertension was associated with a lower PP (OR: 6.7, 95% CI: 0.8-53.9), whereas the presence of hyperparathyroidism was associated with higher PP and SP (OR: 0.2, 95% CI: 0.1-0.7). In contrast, PP and SP in patients with perforating vein AVF were not influenced by comorbidities.
CONCLUSIONS: Perforating vein AVF is superior to forearm AVF in elderly patients with diabetes and arterial hypertension due to the proximal fistula location, probably caused by an improved artery distensibility during fistula maturation.

Entities:  

Mesh:

Year:  2011        PMID: 21325347     DOI: 10.1093/ndt/gfr004

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Relevance of a skilled vascular surgeon and optimized facility practices in the long-term patency of arteriovenous fistulas: a prospective study.

Authors:  Esteban Lucas Siga; Noemi Ibalo; Maria R Benegas; Farias Laura; Carlos Luna; David H Aiziczon; Elvio Demicheli
Journal:  J Bras Nefrol       Date:  2019-04-11

2.  The first fistula: influence of location on catheter use and the influence of catheter use on maturation.

Authors:  Charles J Diskin; Thomas J Stokes; Linda M Dansby; Lautrec Radcliff; Thomas B Carter; Allen Lazenby
Journal:  Int Urol Nephrol       Date:  2015-08-04       Impact factor: 2.370

Review 3.  The vascular access in the elderly: a position statement of the Vascular Access Working Group of the Italian Society of Nephrology.

Authors:  Carlo Lomonte; Giacomo Forneris; Maurizio Gallieni; Luigi Tazza; Mario Meola; Massimo Lodi; Massimo Senatore; Walter Morale; Monica Spina; Marcello Napoli; Decenzio Bonucchi; Franco Galli
Journal:  J Nephrol       Date:  2016-01-16       Impact factor: 3.902

4.  Feasibility for arteriovenous fistula creation with Ellipsys®.

Authors:  Gilbert Franco; Alexandros Mallios; Pierre Bourquelot; Hadia Hebibi; William Jennings; Benoit Boura
Journal:  J Vasc Access       Date:  2020-01-13       Impact factor: 2.283

5.  Ultrasound evaluation of percutaneously created arteriovenous fistulae between radial artery and perforating vein at the elbow.

Authors:  Gilbert Franco; Alexandros Mallios; Pierre Bourquelot; William Jennings; Benoit Boura
Journal:  J Vasc Access       Date:  2020-01-10       Impact factor: 2.283

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.